Evidence map›Paper›PMID 37554669›Full record

ArticleUrology case reports2023

Late relapsing testicular cancer detected with 18F-FDG PET preceded by long-term alpha-fetoprotein elevation.

Hiromichi Sakurai, Akinobu Katami, Hiroshi Yuki, Ryosuke Matsuoka, Koji Kawai, Takayuki Shiomi, Jun Miyazaki

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiromichi SakuraiDepartment of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Akinobu KatamiDepartment of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Hiroshi YukiDepartment of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Ryosuke MatsuokaDepartment of Pathology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Koji KawaiDepartment of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Takayuki ShiomiDepartment of Pathology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Jun MiyazakiDepartment of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late relapse (LR) of testicular cancer is often associated with chemoresistance, and thus the first choice of therapy is surgery if complete resection is possible. In some LR cases (including our patient, a 31-year-old Japanese man), elevation of alpha-fetoprotein (AFP) may precede the radiologic detection of LR. Approximately 500 days after the start of our patient's AFP elevation, 18F-fluordeoxyglucose positron emission tomography (FDG-PET) revealed strong FDG uptake in an equivocally enlarged external iliac lymph node. The lymphadenectomy as salvage surgery resulted in long-term complete remission without further treatment. Using FDG-PET made it possible to perform effective salvage surgery.

Indexed as

18F-fluordeoxyglucose positron emission tomographyAlpha-fetoproteinLate relapseTesticular cancer

Identifiers

PMID37554669
PMCPMC10404854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.